Asiri Surgical Hospital PLC (COSE:AMSL.N0000)
12.00
0.00 (0.00%)
At close: May 9, 2025
Asiri Surgical Hospital Income Statement
Financials in millions LKR. Fiscal year is April - March.
Millions LKR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2015 - 2019 |
Revenue | 6,968 | 6,620 | 5,635 | 5,838 | 4,230 | 3,655 | Upgrade
|
Revenue Growth (YoY) | 6.47% | 17.48% | -3.48% | 38.02% | 15.73% | 5.17% | Upgrade
|
Cost of Revenue | 4,110 | 3,950 | 3,405 | 3,378 | 2,661 | 2,266 | Upgrade
|
Gross Profit | 2,858 | 2,670 | 2,229 | 2,460 | 1,568 | 1,389 | Upgrade
|
Selling, General & Admin | 1,973 | 1,613 | 1,274 | 1,042 | 893.14 | 929.86 | Upgrade
|
Operating Expenses | 1,973 | 1,613 | 1,274 | 1,042 | 893.14 | 929.86 | Upgrade
|
Operating Income | 884.46 | 1,057 | 954.96 | 1,418 | 675.12 | 459.21 | Upgrade
|
Interest Expense | -352.92 | -617.88 | -952.25 | -247.04 | -245.53 | -146.54 | Upgrade
|
Interest & Investment Income | 490.85 | 767.97 | 1,218 | 247.39 | 246.34 | 210.36 | Upgrade
|
Earnings From Equity Investments | - | - | - | - | - | 0.9 | Upgrade
|
Currency Exchange Gain (Loss) | 8.22 | 8.22 | 5.17 | -8.01 | 0.94 | -0.61 | Upgrade
|
Other Non Operating Income (Expenses) | 75.43 | 46.08 | 35.33 | 53.34 | 31.04 | 75.7 | Upgrade
|
EBT Excluding Unusual Items | 1,106 | 1,262 | 1,261 | 1,464 | 707.9 | 599.03 | Upgrade
|
Gain (Loss) on Sale of Investments | - | - | 0.43 | 7.08 | - | - | Upgrade
|
Gain (Loss) on Sale of Assets | -0.02 | -0.02 | -0.44 | -0.67 | 0.86 | -10.34 | Upgrade
|
Asset Writedown | - | - | - | - | - | 19.21 | Upgrade
|
Pretax Income | 1,106 | 1,262 | 1,261 | 1,470 | 708.77 | 607.9 | Upgrade
|
Income Tax Expense | 433.68 | 515.28 | 621.37 | 223.6 | -150.9 | 174.79 | Upgrade
|
Earnings From Continuing Operations | 672.34 | 746.31 | 640.03 | 1,246 | 859.67 | 433.11 | Upgrade
|
Minority Interest in Earnings | -100.62 | -91.46 | -84.91 | -61.62 | -37.51 | - | Upgrade
|
Net Income | 571.72 | 654.84 | 555.12 | 1,185 | 822.16 | 433.11 | Upgrade
|
Net Income to Common | 571.72 | 654.84 | 555.12 | 1,185 | 822.16 | 433.11 | Upgrade
|
Net Income Growth | 15.01% | 17.96% | -53.14% | 44.10% | 89.83% | 18.17% | Upgrade
|
Shares Outstanding (Basic) | 528 | 528 | 528 | 528 | 528 | 528 | Upgrade
|
Shares Outstanding (Diluted) | 528 | 528 | 528 | 528 | 528 | 528 | Upgrade
|
EPS (Basic) | 1.08 | 1.24 | 1.05 | 2.24 | 1.56 | 0.82 | Upgrade
|
EPS (Diluted) | 1.08 | 1.24 | 1.05 | 2.24 | 1.56 | 0.82 | Upgrade
|
EPS Growth | 15.01% | 17.96% | -53.14% | 44.10% | 89.83% | 18.78% | Upgrade
|
Free Cash Flow | -828.95 | 98.98 | 248.36 | 863.27 | 431.56 | 58.32 | Upgrade
|
Free Cash Flow Per Share | -1.57 | 0.19 | 0.47 | 1.63 | 0.82 | 0.11 | Upgrade
|
Dividend Per Share | 0.300 | - | - | 2.100 | 0.850 | - | Upgrade
|
Dividend Growth | - | - | - | 147.06% | - | - | Upgrade
|
Gross Margin | 41.01% | 40.33% | 39.56% | 42.13% | 37.08% | 38.01% | Upgrade
|
Operating Margin | 12.69% | 15.97% | 16.95% | 24.29% | 15.96% | 12.57% | Upgrade
|
Profit Margin | 8.21% | 9.89% | 9.85% | 20.29% | 19.44% | 11.85% | Upgrade
|
Free Cash Flow Margin | -11.90% | 1.49% | 4.41% | 14.79% | 10.20% | 1.60% | Upgrade
|
EBITDA | 1,280 | 1,469 | 1,298 | 1,736 | 987.38 | 703.96 | Upgrade
|
EBITDA Margin | 18.37% | 22.18% | 23.03% | 29.74% | 23.34% | 19.26% | Upgrade
|
D&A For EBITDA | 395.29 | 411.39 | 342.75 | 318.43 | 312.26 | 244.74 | Upgrade
|
EBIT | 884.46 | 1,057 | 954.96 | 1,418 | 675.12 | 459.21 | Upgrade
|
EBIT Margin | 12.69% | 15.97% | 16.95% | 24.29% | 15.96% | 12.57% | Upgrade
|
Effective Tax Rate | 39.21% | 40.84% | 49.26% | 15.21% | - | 28.75% | Upgrade
|
Advertising Expenses | - | 26.42 | 26.35 | 25.14 | 14.24 | 18.57 | Upgrade
|
Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.